CD73-IN-12

• UNSPSC Description:

  CD73-IN-12 is a potent inhibitor of CD73. CD73 is closely associated with tumor growth, angiogenesis and metastasis. CD73-IN-12 be used for preparing a medicament for tumor-related diseases (extracted from patent CN114437038A, compound 9)[1]. CD73-IN-12 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.

• Target Antigen:

  CD73

• Type:

  Reference compound

• Related Pathways:

  Immunology/Inflammation

• Applications:

  Cancer-programmed cell death

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/cd73-in-12.html

• Solubility:

  10 mM in DMSO

• Smiles:

  O=C1NC=C(C(N1)=O)C2=NN=C(C([C@@H]3C[C@H]3C(F)F)=C2)C#CC4CC4

• Molecular Weight:

  344.32

• References & Citations:

  [1]Xuejun Zhang, et al. Pyridazine alkyne compound and application thereof. Patent CN114437038A.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  2773502-79-5